SCHEMBL4960293

SCHEMBL4960293

COc1ccc(N(C(=O)[C@H]2CCCNC2)C2CCCCC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 6/20 0.50
CDK9 P50750 1/20 0.42
REN P00797 1/20 0.42
RPLP1 P05386 2/20 0.41
RPLP0 P05388 2/20 0.41
RPS17 P08708 2/20 0.41
RPSA P08865 2/20 0.41
RPS2 P15880 2/20 0.41
RPL35A P18077 2/20 0.41
RPL7 P18124 2/20 0.41
RPL17 P18621 2/20 0.41
RPS4Y1 P22090 2/20 0.41
RPS3 P23396 2/20 0.41
RPS12 P25398 2/20 0.41
RPL13 P26373 2/20 0.41
RPL10 P27635 2/20 0.41
RPL12 P30050 2/20 0.41
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 2/20 0.41
RPL22 P35268 2/20 0.41
RPL4 P36578 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960546 0.86 MTNR1A (0.44) TRPM8CDK9RENNPC1RAB9A
SCHEMBL4961872 0.86 SLC6A2 (0.46) TRPM8CDK9KCNH2NPC1RAB9A
SCHEMBL4963040 0.84 CHRM2 (0.52) TRPM8CDK9KCNH2NPC1RAB9A
SCHEMBL4962814 0.84 CHRM2 (0.52) TRPM8CDK9KCNH2NPC1RAB9A
SCHEMBL4961245 0.82 MLYCD (0.41) KCNH2
SCHEMBL25194772 0.78 RPLP1 (0.49) TRPM8RPLP1RPLP0RPS17RPSA
SCHEMBL4962731 0.78 TRPM8 (0.41) TRPM8CDK9RENKCNH2NPC1
Hydrochloric Acid SCHEMBL4000833 0.76 SLC6A2 (0.47) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4961292 0.75 CHRM2 (0.48) TRPM8CDK9RENRPLP1RPLP0
SCHEMBL4961968 0.75 LMNA (0.58) CDK9RPLP1RPLP0RPS17RPSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 EP claimed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 EP claimed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 WO claimed
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 EP disclosed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 EP disclosed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 WO disclosed